These antigens derived from the well-described melanoma antigens MART-1, NY-ESO-1, MAGE-3 and gp100 and have been shown to be widely recognized by T cells, either spontaneously or following immunotherapy (16–19). The gene discussed is PMEL; the disease is melanoma.